NBIX vs. VOO
Compare and contrast key facts about Neurocrine Biosciences, Inc. (NBIX) and Vanguard S&P 500 ETF (VOO).
VOO is a passively managed fund by Vanguard that tracks the performance of the S&P 500 Index. It was launched on Sep 7, 2010.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NBIX or VOO.
Correlation
The correlation between NBIX and VOO is 0.40, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
NBIX vs. VOO - Performance Comparison
Key characteristics
NBIX:
0.39
VOO:
2.04
NBIX:
0.71
VOO:
2.72
NBIX:
1.11
VOO:
1.38
NBIX:
0.48
VOO:
3.02
NBIX:
1.05
VOO:
13.60
NBIX:
12.29%
VOO:
1.88%
NBIX:
33.38%
VOO:
12.52%
NBIX:
-97.21%
VOO:
-33.99%
NBIX:
-11.56%
VOO:
-3.52%
Returns By Period
In the year-to-date period, NBIX achieves a 2.80% return, which is significantly lower than VOO's 24.65% return. Over the past 10 years, NBIX has outperformed VOO with an annualized return of 18.69%, while VOO has yielded a comparatively lower 13.02% annualized return.
NBIX
2.80%
15.16%
3.51%
11.48%
4.30%
18.69%
VOO
24.65%
-0.29%
7.63%
24.77%
14.57%
13.02%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
NBIX vs. VOO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Neurocrine Biosciences, Inc. (NBIX) and Vanguard S&P 500 ETF (VOO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
NBIX vs. VOO - Dividend Comparison
NBIX has not paid dividends to shareholders, while VOO's dividend yield for the trailing twelve months is around 1.26%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NBIX Neurocrine Biosciences, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
VOO Vanguard S&P 500 ETF | 1.26% | 1.46% | 1.69% | 1.25% | 1.54% | 1.88% | 2.06% | 1.78% | 2.02% | 2.10% | 1.85% | 1.84% |
Drawdowns
NBIX vs. VOO - Drawdown Comparison
The maximum NBIX drawdown since its inception was -97.21%, which is greater than VOO's maximum drawdown of -33.99%. Use the drawdown chart below to compare losses from any high point for NBIX and VOO. For additional features, visit the drawdowns tool.
Volatility
NBIX vs. VOO - Volatility Comparison
Neurocrine Biosciences, Inc. (NBIX) has a higher volatility of 7.24% compared to Vanguard S&P 500 ETF (VOO) at 3.58%. This indicates that NBIX's price experiences larger fluctuations and is considered to be riskier than VOO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.